Navigation Links
Charm Amphenicol Test Achieves ILVO Validation
Date:6/22/2017

Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol (AMPH) test has completed ILVO validation. The AMPH test was determined to be appropriate as a screening test at dairies and farms for raw commingled cow milk. The test was evaluated for visual interpretation, on the Charm EZ system, and the Charm EZ Lite system. These systems are a combination incubator and reader in one.

“The AMPH test enables dairies and food manufacturers to detect florfenicol in raw commingled milk as well as detecting thiamphenicol and the banned antibiotic chloramphenicol,” said Robert Salter, Vice President of Regulatory Affairs. “These antibiotics are not intended for use in lactating animals that produce milk for human consumption, but veterinarians may use florfenicol for animal health and welfare. Florfenicol appears in the top 20 animal drugs in a milk residue risk ranking done by FDA-CVM (Center for Veterinary Medicine) in 2015. It is important to give farmers and dairies a quick and accurate method of detection to verify the residue can no longer be detected in the milk when this drug has been used. The ILVO validation is a third party validation to demonstrate the method is suitable for purpose as a raw milk screening test.”

Residue free raw milk yields negative results greater than 99% of the time. The AMPH method meets EU MRL and EU MRPL sensitivity regulations, and US Tolerance Levels.

About Charm Sciences, Inc.
Charm Sciences is a leading world provider of food safety, water quality and environmental diagnostics. Charm’s diagnostics portfolio includes test kits and systems for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end product microbial assessment, allergen control, water quality and ATP hygiene. Directly and through its network of distributors, Charm products serve the food, beverage, water, pharmaceutical, medical, personal care, environmental, and industrial markets in more than 100 countries. Customers rely on Charm products for excellence in quality, innovation and customer support.

About ILVO
ILVO, Flanders research institute for agriculture, fisheries and food (Melle, Belgium), is the EU reference laboratory for antibiotics and the national reference laboratory of Belgium. ILVO performs screening test validations according to the European Commission Central Reference Laboratory Screening Test Guidelines also being adopted by the International Dairy Federation.

About FDA Risk & Safety Assessment
“The Food and Drug Administration (FDA) uses risk analysis, a concept and framework fostered by the World Health Organization, to ensure that regulatory decisions about foods are science-based and transparent.” The Multicriteria-based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products was released in April 2015. To learn more, visit http://www.fda.gov.

© 2017 Charm Sciences, Inc. Charm and Charm EZ are registered trademarks of Charm Sciences, Inc.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14451760.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Charm Sciences Announces New Sales/Business Manager
2. Charm Sciences Introduces the Peel Plate Colony Counter for Quantifying Microbial Colonies
3. Charm TRIO Test Receives AOAC Certification
4. Charm CowSide II Test Achieves ILVO Validation
5. Charm Peel Plate YM (Yeast and Mold) Microbial Test Receives AOAC-RI Approval
6. Charm Sciences Announces FDA Release of 2400 Forms for Charm Peel Plate AC and EC Microbial Tests
7. Charm Peel Plate AC (Aerobic Count) Microbial Test Receives AOAC-RI Approval
8. USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences
9. New Charm Peel Plate EC Offers Significant Advantages in Traditional Coliform Count Testing — Awarded AOAC-RI Performance Test Method Status
10. USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences
11. Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):